Concurrent Antiphospholipid Syndrome and Sutaneous Sarcoidosis Due toInterferon Alfa and Ribavirin Treatment for Hepatitis C
September 2009 | Volume 8 | Issue 9 | Case Reports | 870 | Copyright © September 2009
Michi M. Shinohara MD, Claudia Davis ARNP, John Olerud MD
Abstract
Autoimmune phenomena are common in both hepatitis C infection and interferon alfa treatment; however, the development of
antiphospholipid syndrome is rare. This article reports the case of a patient who developed antiphospholipid syndrome in addition to
cutaneous sarcoidosis in the setting of pegylated interferon alfa and ribavirin treatment for hepatitis C. 
